It was demonstrated that transgenic mice expressing constitutively active AKT (CA-AKT1) in β-cells show a significant increase in the mass of Langerhans islets, better glucose tolerance, and resistance to experimentally induced diabetes [50]. Here, AKT1 is linked to diabetes mellitus.